PARIS & BOSTON–(BUSINESS WIRE)–Regulatory News: Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform, today announces the clinical launch of CellTolerance at Cleveland Clinic Abu Dhabi, part of the M42 network and ranked the Middle East’s top gastroenterology hospital by Newsweek (see Cleveland Clinic Abu Dhabi’s announcement). Following UAE market authorization by the Emirates Dru